INTELLIPHARMACEUTICS ANNOUNCES AGREEMENT FOR DEVELOPMENT OF CONTROLLED RELEASE PRODUCT

IntelliPharmaCeutics Corp. of Toronto, Ontario is pleased to announce that it has entered into an agreement with ratiopharm inc. of Mississauga, Ontario, for the development of a generic, controlled release drug product for the Canadian market. IntelliPharmaCeutics Corp. is a Canadian specialty drug development company, and operating affiliate of IntelliPharmaCeutics Ltd., (Delaware). ratiopharm develops, manufactures, markets and distributes generic pharmaceutical products in Canada.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1129609XSL_NEWSML_TO_NEWSML_WEB.xml)